|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
-3.96/-0.02
|
Enterprise Value
4.14M
|
Balance Sheet |
Book Value Per Share
0.04
|
Cash Flow |
Cash Flow Yield
--
|
Income Statement |
Total Revenue
14.73M
|
Operating Revenue Per Share
0.42
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Quotes are at least 15-min delayed:2024/05/16 04:04 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratorytested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare. |